Back to Search Start Over

New Factor Xa Findings from National Cerebral and Cardiovascular Center Outlined (Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the Annexa-4 Study In Japan).

Source :
Clinical Trials Week; 10/3/2023, p237-237, 1p
Publication Year :
2023

Abstract

Osaka, Japan, Asia, Blood Coagulation Factors, Blood Proteins, Enzymes and Coenzymes, Factor Xa, Health and Medicine, Hematology, Peptide Hydrolases, Serine Endopeptidases Keywords: Osaka; Japan; Asia; Blood Coagulation Factors; Blood Proteins; Enzymes and Coenzymes; Factor Xa; Health and Medicine; Hematology; Peptide Hydrolases; Serine Endopeptidases EN Osaka Japan Asia Blood Coagulation Factors Blood Proteins Enzymes and Coenzymes Factor Xa Health and Medicine Hematology Peptide Hydrolases Serine Endopeptidases 237 237 1 10/03/23 20231003 NES 231003 2023 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators discuss new findings in Proteins - Factor Xa. Keywords for this news article include: Osaka, Japan, Asia, Asia, Blood Coagulation Factors, Blood Proteins, Enzymes and Coenzymes, Factor Xa, Health and Medicine, Hematology, Japan, Peptide Hydrolases, Serine Endopeptidases, National Cerebral and Cardiovascular Center. [Extracted from the article]

Details

Language :
English
ISSN :
15436772
Database :
Complementary Index
Journal :
Clinical Trials Week
Publication Type :
Periodical
Accession number :
172407375